Announcement

Collapse
No announcement yet.

Stanford/SCVMC landmark stem cell therapy trialteam treats final patient in

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Stanford/SCVMC landmark stem cell therapy trialteam treats final patient in

    Stanford/SCVMC landmark stem cell therapy trialteam treats final patient in
    BY KRISTA CONGER


    Gary Steinberg

    The Stanford University School of Medicine and Santa Clara Valley Medical Center treated the fifth patient in the Geron Corp-sponsored trial of a human embryonic-stem-cell-derived treatment for severe spinal cord injury on Nov. 16.

    The patient, who is the second to be treated at Stanford and SCVMC, was enrolled in the trial before Geron announced on Nov. 14 that it was discontinuing the trial. The patient elected to undergo the procedure after being informed of the trial’s status.

    “The procedure went smoothly and the patient is doing extremely well,” said Stanford neurosurgeon Gary Steinberg, MD, PhD. “Although the decision by Geron to discontinue the trial was disappointing, I am confident that stem cell science will continue to move forward as we and others work to translate promising laboratory findings into clinical benefits for patients.” Steinberg, the Bernard and Ronni Lacroute-William Randolph Hearst Professor in Neurosurgery and Neurosciences at Stanford, is the principal investigator of the Stanford/SCVMC portion of the trial, and implanted the cells in the patient at the Rehabilitation Trauma Center at SCVMC.

    Geron, based in Menlo Park, Calif., developed and manufactured the cells. The phase-1 trial was designed to test the safety of the cells in human patients. Although Geron has discontinued the trial to instead focus on new cancer treatments, the company will continue to monitor the five patients who have received the cells for a total of 15 years and is actively looking for partners to “enable further development of its stem cell programs.”

    read....

    http://med.stanford.edu/ism/2011/november/geron.html

    #2
    Landmark Spinal Repair Stem Cell Trial


    http://www.medicalnewstoday.com/articles/238014.php

    Comment


      #3
      Originally posted by manouli View Post
      Stanford/SCVMC landmark stem cell therapy trialteam treats final patient in
      BY KRISTA CONGER


      Gary Steinberg

      The Stanford University School of Medicine and Santa Clara Valley Medical Center treated the fifth patient in the Geron Corp-sponsored trial of a human embryonic-stem-cell-derived treatment for severe spinal cord injury on Nov. 16.

      The patient, who is the second to be treated at Stanford and SCVMC, was enrolled in the trial before Geron announced on Nov. 14 that it was discontinuing the trial. The patient elected to undergo the procedure after being informed of the trial’s status.

      “The procedure went smoothly and the patient is doing extremely well,” said Stanford neurosurgeon Gary Steinberg, MD, PhD. “Although the decision by Geron to discontinue the trial was disappointing, I am confident that stem cell science will continue to move forward as we and others work to translate promising laboratory findings into clinical benefits for patients.” Steinberg, the Bernard and Ronni Lacroute-William Randolph Hearst Professor in Neurosurgery and Neurosciences at Stanford, is the principal investigator of the Stanford/SCVMC portion of the trial, and implanted the cells in the patient at the Rehabilitation Trauma Center at SCVMC.

      Geron, based in Menlo Park, Calif., developed and manufactured the cells. The phase-1 trial was designed to test the safety of the cells in human patients. Although Geron has discontinued the trial to instead focus on new cancer treatments, the company will continue to monitor the five patients who have received the cells for a total of 15 years and is actively looking for partners to “enable further development of its stem cell programs.”

      read....

      http://med.stanford.edu/ism/2011/november/geron.html
      Good for Stanford. Wise.

      Comment


        #4
        Very good for academia Stanford and SCI. Standford University (academia) 'push'.

        Comment

        Working...
        X